ClinicalTrials.gg
CompletedNCT05123547DENTA-VIHUpdated May 19, 2022

DENTAL CARE OF PATIENTS LIVING WITH HIV

An observational study in HIV Infections, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-19.

Sponsored by University Hospital, Clermont-Ferrand · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
112
Ages
18 Years and older
Sex
All
01

Study summary

This study is perform to identify oral diseases of people living with HIV (PLWHIV) or co-infected with HBV or HCV.

Read the detailed description

In the purpose of identifying oral diseases of people living with HIV (PLWHIV) or co-infected with HBV or HCV, we would recruit from 15 10 2021 to 15 04 2022 affiliated to social security scheme PLWHIV adults followed-up in the infectious diseases department of Clermont-Ferrand university hospital who accept participate in order to propose dental individual clinical exams. Anonymous socio-demograpic, medical and dental data will be reported in Redcap. Primary outcomes are the number and type of pathologies identified linked to HIV or not. Statistical analysed will be performed with Stata software. The population will be described by associated numbers and percentages for the categorical variables and by the mean ± standard deviation or median [interquartile interval] for the quantitative variables, with respect to their statistical distribution.

02

Conditions studied

  • HIV Infections

Browse trials for

Keywords

  • HIV
  • Dental care
03

In context

HIV Infections

4,342 studies on the registry are indexed under HIV Infections; 240 are open to participants now.

This study's enrollment of 112 is below the median of 200 across 731 observational studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 854 studies on the registry; 180 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

people living with HIV

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient infected with HIV or co-infected with HIV / HBV or HIV / HCV followed in the Infectious Diseases department of Clermont-Ferrand University Hospital and affiliated to a social security scheme.

Exclusion criteria

Exclusion Criteria:

  • Minor patient
  • Adult patient unable to express his non-opposition to participating in the study or patient who refuses to participate in the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
112 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. description of oral disease linked to HIV or not.

    percentage of patients with oral disease linked to HIV and percentage of patients with oral disease not linked to HIV

    Time frame: During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand

Secondary outcomes

  1. Study the factors associated with the presence of oral pathologies linked to HIV.

    bivariate and multivariate analysis of demographic, immunovirologic factors and comorbidities associated to oral diseases linked to HIV

    Time frame: During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand

  2. Study the factors associated with the presence of oral pathologies unrelated to HIV.

    bivariate and multivariate analysis of demographic, immunovirologic factors and comorbidities associated with the presence of oral pathologies unrelated to HIV

    Time frame: During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand

  3. Compare the prevalence of oral pathologies linked or not to HIV with that found in a previous study carried out in 2003.

    comparison of prevalence of oral diseases in 2021 and those in 2003 in CHU Clermont Ferrand

    Time frame: During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand

  4. List the course of dental care of these people during the last 3 years.

    % refusal care, % lost of dental follow-up

    Time frame: During the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrand

07

Study locations

1 site
  • CHU clermont-ferrand
    Clermont-Ferrand, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05123547
Responsible party
Sponsor
First posted
Nov 17, 2021
Start date
Oct 21, 2021
Primary completion
Apr 21, 2022
Completion
Apr 21, 2022
Last update
May 19, 2022

Study contacts

Christine JACOMET
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion